InvestorsHub Logo

attilathehunt

01/02/24 2:13 PM

#445371 RE: tobiasjosias #445364

I'd wait to double down...There will be months of silence as they forge an angle to submit AD to the EMA...

Wouldn't be surprised to see sub $4 in the quite period now looming over us... I will reconsider entry at 2.90

bas2020

01/02/24 2:14 PM

#445372 RE: tobiasjosias #445364

Paid FUDsters, including AF, spin negative narratives even when the results are exceedingly positive to provide a smokescreen for the collusive HF cabal behind the scenes with their manipulation schemes.

The results today, showing 3X the efficacy of Daybue, combined with the impending genetic data and RWE of real patients improving (e.g. reduced seizures) and safety profile, is clear evidence of a successful drug for Rett. I fully expect that an NDA will be submitted after review with the FDA.

AD is already on the approval path with the EMA.

All indications are pointing upward.

I added 50% additional shares the last time we were manipulated down to $5. I doubt we get back to there, when there's positive news in the waiting.